These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 34726551)
1. Design of experiments and multivariate analysis approach to study dissolution stability of a modified-release drug product to support lean design strategies. Jordan N; Roškar R; Grabnar I Drug Dev Ind Pharm; 2021 Sep; 47(9):1481-1488. PubMed ID: 34726551 [TBL] [Abstract][Full Text] [Related]
2. A Quality by Design approach to investigate tablet dissolution shift upon accelerated stability by multivariate methods. Huang J; Goolcharran C; Ghosh K Eur J Pharm Biopharm; 2011 May; 78(1):141-50. PubMed ID: 21168490 [TBL] [Abstract][Full Text] [Related]
3. Applying the methodology of Design of Experiments to stability studies: a Partial Least Squares approach for evaluation of drug stability. Jordan N; Zakrajšek J; Bohanec S; Roškar R; Grabnar I Drug Dev Ind Pharm; 2018 May; 44(5):778-786. PubMed ID: 29192517 [TBL] [Abstract][Full Text] [Related]
4. Prediction of the Long-Term Dissolution Performance of an Immediate-Release Tablet Using Accelerated Stability Studies. Scrivens G J Pharm Sci; 2019 Jan; 108(1):506-515. PubMed ID: 30595168 [TBL] [Abstract][Full Text] [Related]
5. Developing a quality by design approach to model tablet dissolution testing: an industrial case study. Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A Pharm Dev Technol; 2018 Jul; 23(6):646-654. PubMed ID: 29092662 [TBL] [Abstract][Full Text] [Related]
6. Hybridized nanoamorphous micellar dispersion using a QbD-DM Rathod V; Stagner WC; Gajera B; Haware RV Int J Pharm; 2020 Oct; 588():119727. PubMed ID: 32758594 [TBL] [Abstract][Full Text] [Related]
7. The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability. Waterman KC AAPS PharmSciTech; 2011 Sep; 12(3):932-7. PubMed ID: 21748541 [TBL] [Abstract][Full Text] [Related]
8. Current perspectives on the dissolution stability of solid oral dosage forms. Murthy KS; Ghebre-Sellassie I J Pharm Sci; 1993 Feb; 82(2):113-26. PubMed ID: 8445522 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Discriminatory Dissolution Model for an Immediately Release Dosage Form by DOE and Statistical Approaches. Fu M; Conroy E; Byers M; Pranatharthiharan L; Bilbault T AAPS PharmSciTech; 2021 Apr; 22(4):140. PubMed ID: 33884530 [TBL] [Abstract][Full Text] [Related]
10. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets. Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852 [TBL] [Abstract][Full Text] [Related]
11. Quality-by-design case study: investigation of the role of poloxamer in immediate-release tablets by experimental design and multivariate data analysis. Kaul G; Huang J; Chatlapalli R; Ghosh K; Nagi A AAPS PharmSciTech; 2011 Dec; 12(4):1064-76. PubMed ID: 21861241 [TBL] [Abstract][Full Text] [Related]
12. Crystallization Risk Assessment of Amorphous Solid Dispersions by Physical Shelf-Life Modeling: A Practical Approach. Liu B; Theil F; Lehmkemper K; Gessner D; Li Y; van Lishaut H Mol Pharm; 2021 Jun; 18(6):2428-2437. PubMed ID: 34032433 [TBL] [Abstract][Full Text] [Related]
13. Quality by design approach for formulation development: a case study of dispersible tablets. Charoo NA; Shamsher AA; Zidan AS; Rahman Z Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997 [TBL] [Abstract][Full Text] [Related]
14. Application of Quality by Design (QbD) Principles to Extractables/Leachables Assessment. Establishing a Design Space for Terminally Sterilized Aqueous Drug Products Stored in a Plastic Packaging System. Jenke D PDA J Pharm Sci Technol; 2010; 64(6):527-35. PubMed ID: 21502063 [TBL] [Abstract][Full Text] [Related]
15. A Bayesian Approach to Kinetic Modeling of Accelerated Stability Studies and Shelf Life Determination. Chau J; Altan S; Burggraeve A; Coppenolle H; Kifle YW; Prokopcova H; Van Daele T; Sterckx H AAPS PharmSciTech; 2023 Nov; 24(8):250. PubMed ID: 38036798 [TBL] [Abstract][Full Text] [Related]
16. Primary packaging considerations in developing medicines for children: oral liquid and powder for constitution. Campbell GA; Vallejo E J Pharm Sci; 2015 Jan; 104(1):52-62. PubMed ID: 25393927 [TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software. Fu M; Perlman M; Lu Q; Varga C J Pharm Biomed Anal; 2015 Mar; 107():370-7. PubMed ID: 25656488 [TBL] [Abstract][Full Text] [Related]
19. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets. Azhakesan A; Kuppusamy S J AOAC Int; 2022 Mar; 105(2):370-378. PubMed ID: 34894249 [TBL] [Abstract][Full Text] [Related]
20. Understanding and predicting the impact of critical dissolution variables for nifedipine immediate release capsules by multivariate data analysis. Mercuri A; Pagliari M; Baxevanis F; Fares R; Fotaki N Int J Pharm; 2017 Feb; 518(1-2):41-49. PubMed ID: 28011342 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]